SALDANHA; Jose
Patent Applications and Registrations
Patent applications and USPTO patent grants for SALDANHA; Jose.The latest application filed is for "treatment and prophylaxis of amyloidosis".
Company Profile
4.22.27
- SALDANHA; Jose - ENFIELD GB
- Saldanha; Jose - Middlesex GB
- Saldanha; Jose - Enfield Middlesex GB
Patent Activity
| Patent | Date |
|---|---|
| Treatment and Prophylaxis of Amyloidosis App 20210008185 - SCHENK; Dale B. ; et al. | 2021-01-14 |
| Humanized antibodies that recognize alpha-synuclein Grant 10,875,909 - Saldanha , et al. December 29, 2 | 2020-12-29 |
| Humanized Antibodies That Recognize Alpha-Synuclein App 20200277362 - Saldanha; Jose ; et al. | 2020-09-03 |
| Humanized antibodies that recognize alpha-synuclein Grant 10,597,441 - Saldanha , et al. | 2020-03-24 |
| Humanized Antibodies That Recognize Alpha-Synuclein App 20190153080 - Saldanha; Jose ; et al. | 2019-05-23 |
| Treatment And Prophylaxis Of Amyloidosis App 20180360934 - SCHENK; DALE B. ; et al. | 2018-12-20 |
| Humanized antibodies that recognize alpha-synuclein Grant 10,118,960 - Saldanha , et al. November 6, 2 | 2018-11-06 |
| Humanized Antibodies That Recognize Alpha-Synuclein App 20180016329 - Saldanha; Jose ; et al. | 2018-01-18 |
| Humanized antibodies that recognize alpha-synuclein Grant 9,670,273 - Saldanha , et al. June 6, 2 | 2017-06-06 |
| Treatment And Prophylaxis Of Amyloidosis App 20170081396 - SCHENK; DALE B. ; et al. | 2017-03-23 |
| Humanized Antibodies That Recognize Alpha-Synuclein App 20160251416 - Saldanha; Jose ; et al. | 2016-09-01 |
| Humanized antibodies that recognize alpha-synuclein Grant 9,234,031 - Saldanha , et al. January 12, 2 | 2016-01-12 |
| Humanized antibodies that recognize alpha-synuclein Grant 9,217,030 - Saldanha , et al. December 22, 2 | 2015-12-22 |
| Treatment And Prophylaxis Of Amyloidosis App 20150158937 - SCHENK; Dale B. ; et al. | 2015-06-11 |
| Therapeutic Uses Of Humanized Antibodies Against Alpha-4 Integrin App 20150064177 - BENDIG; Mary M. ; et al. | 2015-03-05 |
| Humanized Antibodies That Recognize Alpha-Synuclein App 20150056187 - Saldanha; Jose ; et al. | 2015-02-26 |
| Humanized Antibodies That Recognize Alpha-Synuclein App 20150024433 - Saldanha; Jose ; et al. | 2015-01-22 |
| Treatment and prophylaxis of amyloidosis Grant 8,791,243 - Schenk , et al. July 29, 2 | 2014-07-29 |
| Humanized antibodies that recognize alpha-synuclein Grant 8,790,644 - Saldanha , et al. July 29, 2 | 2014-07-29 |
| Treatment And Prophylaxis Of Amyloidosis App 20140134103 - SCHENK; Dale B. ; et al. | 2014-05-15 |
| Humanized antibodies that recognize alpha-synuclein Grant 8,609,820 - Saldanha , et al. December 17, 2 | 2013-12-17 |
| Humanized Antibodies That Recognize Alpha-Synuclein App 20130266517 - Saldanha; Jose ; et al. | 2013-10-10 |
| Humanized Antibodies That Recognize Alpha-Synuclein App 20130108546 - Saldanha; Jose ; et al. | 2013-05-02 |
| Therapeutic Uses of Humanized Antibodies Against ALPHA-4 Integrin App 20130059337 - Bendig; Mary M. ; et al. | 2013-03-07 |
| Anti-amyloid antibodies Grant 8,268,973 - Schenk , et al. September 18, 2 | 2012-09-18 |
| Methods of inhibiting alpha-4-dependent interactions with VCAM-1 with anti-VLA-4 antibodies Grant 8,246,958 - Bendig , et al. August 21, 2 | 2012-08-21 |
| Humanized antibodies that recognize beta amyloid peptide Grant 8,128,928 - Basi , et al. March 6, 2 | 2012-03-06 |
| Humanized antibodies that recognize beta amyloid peptide App 20110142823 - Basi; Guriq ; et al. | 2011-06-16 |
| Humanized antibodies that recognize beta amyloid peptide Grant 7,871,615 - Basi , et al. January 18, 2 | 2011-01-18 |
| Therapeutic Uses Of Humanized Antibodies Against Alpha-4 Integrin App 20100081793 - BENDIG; MARY M. ; et al. | 2010-04-01 |
| Humanized immunoglubulin reactive with alph4beta7 integrin App 20090011464 - Ponath; Paul D. ; et al. | 2009-01-08 |
| Humanized anti-VLA4 immunoglobulins Grant 7,435,802 - Bendig , et al. October 14, 2 | 2008-10-14 |
| Humanized immunoglobulin reactive with .alpha.4.beta.7 integrin Grant 7,402,410 - Ponath , et al. July 22, 2 | 2008-07-22 |
| Humanized antibodies that recognize beta amyloid peptide Grant 7,256,273 - Basi , et al. August 14, 2 | 2007-08-14 |
| Humanized immunoglobulin reactive with alpha4beta7 integrin App 20060292140 - Ponath; Paul D. ; et al. | 2006-12-28 |
| Humanized immunoglobulin reactive with .alpha.4.beta.7 integrin Grant 7,147,851 - Ponath , et al. December 12, 2 | 2006-12-12 |
| Humanized anti-VLA 4 immunoglobulins and uses thereof App 20060110394 - Bendig; Mary M. ; et al. | 2006-05-25 |
| Humanized antibodies that recognize beta amyloid peptide App 20050118651 - Basi, Guriq ; et al. | 2005-06-02 |
| Humanized antibodies that recognize beta amyloid peptide App 20050009150 - Basi, Guriq ; et al. | 2005-01-13 |
| Humanized antibodies that recognize beta amyloid peptide App 20040087777 - Basi, Guriq ; et al. | 2004-05-06 |
| Humanized antibodies that recognize beta amyloid peptide App 20040082762 - Basi, Guriq ; et al. | 2004-04-29 |
| Humanized antibodies that recognize beta amyloid peptide App 20030165496 - Basi, Guriq ; et al. | 2003-09-04 |
| Reshaped monoclonal antibodies against an immunoglobulin isotype Grant 6,072,035 - Hardman , et al. June 6, 2 | 2000-06-06 |
| Reshaped monoclonal antibodies against an immunoglobulin isotype Grant 5,958,708 - Hardman , et al. September 28, 1 | 1999-09-28 |
| Humanized antibodies against leukocyte adhesion molecule VLA-4 Grant 5,840,299 - Bendig , et al. November 24, 1 | 1998-11-24 |
| Humanized and chimeric anti-epidermal growth factor receptor monoclonal antibodies Grant 5,558,864 - Bendig , et al. September 24, 1 | 1996-09-24 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 